IndieBio Batch 2026

IndieBio Batch 2026 is an early-stage accelerator program for biotechnology and deep tech startups administered by IndieBio, a division of the venture capital firm SOSV. Operating from BSL-1 and BSL-2 laboratory facilities in San Francisco and New York, the 100-day program focuses on sectors including artificial intelligence, engineered biology, therapeutics, and climate technology. Selected cohorts of approximately 30 companies receive an investment package ranging from $250,000 to $525,000, requiring at least two full-time co-founders to relocate for the duration. The accelerator operates with backing from entities like Empire State Development and the Genesis Consortium, while portfolio companies frequently interact with the National Institutes of Health and the Food and Drug Administration. This resource is intended for global scientists and early-stage entrepreneurs seeking capital, laboratory infrastructure, and mentorship to transition scientific discoveries into commercialized businesses.

IndieBio is the world's leading biotech accelerator, run by SOSV from their labs in San Francisco. The 2026 batch invests $500,000 for 8-12% equity and runs 16 weeks with access to wet lab space, scientific advisors, and a direct path to $1M+ in SOSV follow-on funding. The deadline is June 15, 2026.

Alumni include Memphis Meats (now Upside Foods), Geltor, and dozens of other biotech companies that have gone on to raise significant venture rounds.

At a Glance

• Program window: 2026 (16 weeks)
• Format: In-person at IndieBio Labs, San Francisco
• Deadline: June 15, 2026
• Funding: $500,000 for 8-12% equity
• Follow-on: $1M+ from SOSV
• Lab space: Full wet lab access included

What You Get

IndieBio provides what most biotech accelerators cannot - actual lab space. You get wet lab access at IndieBio's San Francisco facility, scientific advisors with deep domain expertise, structured mentorship on translating science into viable businesses, and preparation for your next fundraise. The $500K investment is substantial for pre-seed biotech, and SOSV's follow-on commitment means you have a clear path to continued funding.

Who IndieBio Is Looking For

Biotech and life sciences startups with a strong scientific founding team. Pre-seed to seed stage. You should have a clear scientific thesis and the ability to execute experiments during the 16-week program. Focus areas include synthetic biology, diagnostics, therapeutics, agricultural biotech, and environmental biotechnology.